[go: up one dir, main page]

NF-kappa B

"NF-kappa B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.


expand / collapse Publications
This graph shows the total number of publications written about "NF-kappa B" by people in this website by year, and whether "NF-kappa B" was a major or minor topic of these publications.
Below are the most recent publications written about "NF-kappa B" by people in Profiles.
  1. Loss of TRPV4 decreases NFκB-mediated myometrial inflammation and prevents preterm labor. FASEB J. 2025 Feb 28; 39(4):e70418.
    View in: PubMed
  2. Anelloviruses and Cancer. J Infect Dis. 2025 Feb 20; 231(2):298-306.
    View in: PubMed
  3. Macrophage memory emerges from coordinated transcription factor and chromatin dynamics. Cell Syst. 2025 Feb 19; 16(2):101171.
    View in: PubMed
  4. Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV. Sci Adv. 2025 Jan 24; 11(4):eads1911.
    View in: PubMed
  5. The Toxoplasma rhoptry protein ROP55 is a major virulence factor that prevents lytic host cell death. Nat Commun. 2025 Jan 15; 16(1):709.
    View in: PubMed
  6. IRF1 cooperates with ISGF3 or GAF to form innate immune de novo enhancers in macrophages. Sci Signal. 2025 Jan 07; 18(868):eado8860.
    View in: PubMed
  7. BRD4 inhibition rewires cardiac macrophages toward a protective phenotype marked by low MHC class II expression. Am J Physiol Heart Circ Physiol. 2025 Feb 01; 328(2):H294-H309.
    View in: PubMed
  8. Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation. Sci Transl Med. 2024 Dec 11; 16(777):eade5915.
    View in: PubMed
  9. Preventive effect of MitoQ supplementation and endurance training on glioblastoma and its consequences: TLR4/CREB/ NF-κβ /IL-1β pathway and behaviors. Int Immunopharmacol. 2025 Jan 03; 145:113756.
    View in: PubMed
  10. DAB2IP loss in luminal a breast cancer leads to NF-κB-associated aggressive oncogenic phenotypes. JCI Insight. 2024 Dec 06; 9(23).
    View in: PubMed